All In Biotech

Drug Trial Radar · NCT04496167

Safety and Efficacy of EN3835 in Participants With Frozen Shoulder

A Phase 2, Randomized, Double Blind, Placebo Controlled Study of the Safety and Efficacy of EN3835 for the Treatment of Adhesive Capsulitis of the Shoulder

Last checked: Nov 19, 2026Latest source record: Sep 13, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 198 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

198

Actual

Start

Jul 29, 2020

Primary completion

Apr 14, 2022

Study completion Apr 14, 2022

Sponsor

Sponsor type
Industry
First posted
Aug 3, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the safety and efficacy of EN3835 for the treatment of adhesive capsulitis of the shoulder (frozen shoulder).

Conditions

  • Adhesive Capsulitis
  • Frozen Shoulder

Interventions

  • EN3835Drug

    Collagenase clostridium histolyticum

  • PlaceboDrug

    Placebo comparator

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in the Adapted American Shoulder and Elbow Surgeons Shoulder Assessment Form (ASES) Composite Score for the Affected Shoulder at Day 95Time frame: Baseline, Day 95

Locations

38 sites in 1 country. Site status is shown where the registry gives one.

  • Endo Clinical Trial Site #38

    Birmingham, Alabama

  • Endo Clinical Trial Site #24

    Birmingham, Alabama

  • Endo Clinical Trial Site #9

    Mobile, Alabama

  • Endo Clinical Trial Site #29

    Tucson, Arizona

  • Endo Clinical Trial Site #12

    Encinitas, California

  • Endo Clinical Trial Site #16

    Huntington Beach, California

  • Endo Clinical Trial Site #18

    La Mesa, California

  • Endo Clinical Trial Site #14

    Pasadena, California

  • Endo Clinical Trial Site #37

    Denver, Colorado

  • Endo Clinical Trial Site #33

    Bradenton, Florida

  • Endo Clinical Trial Site #3

    Clearwater, Florida

  • Endo Clinical Trial Site #32

    Clermont, Florida

  • Endo Clinical Trial Site #13

    DeLand, Florida

  • Endo Clinical Trial Site #1

    Fort Lauderdale, Florida

  • Endo Clinical Trial Site #2

    Tampa, Florida

  • Endo Clinical Trial Site #20

    Winter Park, Florida

  • Endo Clinical Trial Site #34

    Dalton, Georgia

  • Endo Clinical Trial Site #26

    Lawrenceville, Georgia

  • Endo Clinical Trial Site #30

    Newnan, Georgia

  • Endo Clinical Trial Site #28

    Stockbridge, Georgia

  • Endo Clinical Trial Site #31

    Oak Brook, Illinois

  • Endo Clinical Trial Site #35

    New Orleans, Louisiana

  • Endo Clinical Trial Site #8

    Lincoln, Nebraska

  • Endo Clinical Trial Site #10

    Stony Brook, New York

  • Endo Clinical Trial Site #21

    Durham, North Carolina

  • Endo Clinical Trial Site #36

    Mooresville, North Carolina

  • Endo Clinical Trial Site #6

    Dayton, Ohio

  • Endo Clinical Trial Site #11

    Altoona, Pennsylvania

  • Endo Clinical Trial Site #7

    Indiana, Pennsylvania

  • Endo Clinical Trial Site #5

    State College, Pennsylvania

  • Endo Clinical Trial Site #17

    Bedford, Texas

  • Endo Clinical Trial Site #19

    Bellaire, Texas

  • Endo Clinical Trial Site #15

    Fort Worth, Texas

  • Endo Clinical Trial Site #27

    Georgetown, Texas

  • Endo Clinical Trial Site #25

    Laredo, Texas

  • Endo Clinical Trial Site #23

    Plano, Texas

  • Endo Clinical Trial Site #22

    Plano, Texas

  • Endo Clinical Trial Site #4

    Danville, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.